Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1274692

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1274692

Headache Disorders Global Market Report 2023

Published: Pre-Order
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Headache Disorders Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on headache disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for headache disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The headache disorders market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Migraine; Tension-Type Headache; Cluster Headache; Medication-Overuse Headache; Other Types
  • 2) By Treatment: Medication; Heat Therapy; Diet Changes; Acupuncture; Oxygen Therapy
  • 3) By Diagnosis: Complete Blood Count; Skull X-Rays; Sinus X-Rays; CT Scan; Magnetic Resonance Imaging (MRI)
  • 4) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
  • 5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Hikma Pharmaceuticals PLC; Dr. Reddy's Laboratories Ltd; Novartis AG; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the headache disorders market are Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., and Amgen Inc.

The global headache disorders market is expected to grow from $4.07 billion in 2022 to $4.36 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The headache disorders market is expected to reach $5.71 billion in 2027 at a CAGR of 7%.

The headache disorders market includes revenues earned by entities by providing analgesics, anti-emetics, specific anti-migraine medications, and prophylactic medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Headache disorder is a neurological disorder that is characterized by severe headaches that eoccur on one side of the head, usually around the eye. Headache disorders create a major burden on sufferers, including significant personal pain, decreased quality of life, and financial consequences.

North America was the largest region in the headache disorders market in 2022. The regions covered in headache disorders report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of headache disorders are migraine, tension-type headaches, cluster headaches, medication-overuse headaches, and others. A migraine headache is characterized by intense throbbing pain or a pulsating sensation, typically on one side of the brain. The various treatment involved are medication, heat therapy, diet changes, acupuncture, and oxygen therapy which are diagnosed by complete blood count, skull x-rays, sinus x-rays, ct scans and magnetic resonance imaging (MRI) through oral, parenteral, others and are used for hospitals, specialty clinics, homecare, others.

The increasing prevalence of migraine is expected to propel the growth of the headache disorders market going forward. Migraine refers to a type of headache that is characterized by recurring episodes of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders can cause neurological disorders causing crippling throbbing pain, tiredness, nausea that may cause migraine. For instance, according to Migraine.com, part of US-based Health Union, LLC which provide people living with chronic conditions the information, connection and validation they seek, in 2021, around 39 million people in the United States and 1 billion people worldwide have migraine. Therefore, the increasing prevalence of migraine is driving the demand for the headache disorders market.

Product innovation is a key trend gaining popularity in the headache disorder market. Major companies operating in the headache disorder market are focused on developing innovative products to strengthen their position in the market. For instance, in September 2021, AbbVie, a US-based pharmaceutical company that discovers develops, and markets both biopharmaceuticals and small molecule drugs, launched QULIPTATM (atonement) a prescription medicine for the preventative treatment of episodic migraine in adults. It is uniquely formulated with oral calcitonin gene-related peptide (CGRP) receptor antagonist (giant) in three dose sizes of 10 mg, 30 mg, and 60 mg which are approved by The U.S. Food and Drug Administration (FDA), a US-based department of health.

In May 2022, Man and Science SA, a Belgium-based medical device company, acquired Palion Medical AS for an undisclosed amount. The acquisition of Palion Medical fits well into Man and Science's headache treatment offerings and further drives Man ad Science's ability to provide several therapy solutions to improve patient care. Palion Medical AS a Germany-based clinical-stage medical device company developing a precision injection solution for people suffering from debilitating chronic migraine and cluster headaches.

The countries covered in the headache disorders market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The headache disorders market research report is one of a series of new reports from The Business Research Company that provides headache disorders market statistics, including headache disorders industry global market size, regional shares, competitors with headache disorders market share, detailed headache disorders market segments, market trends, and opportunities, and any further data you may need to thrive in the headache disorders industry. This headache disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Product Code: r6677

Table of Contents

1. Executive Summary

2. Headache Disorders Market Characteristics

3. Headache Disorders Market Trends And Strategies

4. Headache Disorders Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Headache Disorders Market
  • 4.2. Ukraine-Russia War Impact On Headache Disorders Market
  • 4.3. Impact Of High Inflation On Headache Disorders Market

5. Headache Disorders Market Size And Growth

  • 5.1. Global Headache Disorders Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Headache Disorders Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Headache Disorders Market Segmentation

  • 6.1. Global Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Migraine
  • Tension-Type Headache
  • Cluster Headache
  • Medication-Overuse Headache
  • Other Types
  • 6.2. Global Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Medication
  • Heat Therapy
  • Diet Changes
  • Acupuncture
  • Oxygen Therapy
  • 6.3. Global Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Complete Blood Count
  • Skull X-Rays
  • Sinus X-Rays
  • CT Scan
  • Magnetic Resonance Imaging (MRI)
  • 6.4. Global Headache Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administrations
  • 6.5. Global Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Headache Disorders Market Regional And Country Analysis

  • 7.1. Global Headache Disorders Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Headache Disorders Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Headache Disorders Market

  • 8.1. Asia-Pacific Headache Disorders Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Headache Disorders Market

  • 9.1. China Headache Disorders Market Overview
  • 9.2. China Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Headache Disorders Market

  • 10.1. India Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Headache Disorders Market

  • 11.1. Japan Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Headache Disorders Market

  • 12.1. Australia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Headache Disorders Market

  • 13.1. Indonesia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Headache Disorders Market

  • 14.1. South Korea Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Headache Disorders Market

  • 15.1. Western Europe Headache Disorders Market Overview
  • 15.2. Western Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Headache Disorders Market

  • 16.1. UK Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Headache Disorders Market

  • 17.1. Germany Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Headache Disorders Market

  • 18.1. France Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Headache Disorders Market

  • 19.1. Eastern Europe Headache Disorders Market Overview
  • 19.2. Eastern Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Headache Disorders Market

  • 20.1. Russia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Headache Disorders Market

  • 21.1. North America Headache Disorders Market Overview
  • 21.2. North America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Headache Disorders Market

  • 22.1. USA Headache Disorders Market Overview
  • 22.2. USA Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Headache Disorders Market

  • 23.1. South America Headache Disorders Market Overview
  • 23.2. South America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Headache Disorders Market

  • 24.1. Brazil Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Headache Disorders Market

  • 25.1. Middle East Headache Disorders Market Overview
  • 25.2. Middle East Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Headache Disorders Market

  • 26.1. Africa Headache Disorders Market Overview
  • 26.2. Africa Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Headache Disorders Market Competitive Landscape And Company Profiles

  • 27.1. Headache Disorders Market Competitive Landscape
  • 27.2. Headache Disorders Market Company Profiles
    • 27.2.1. Teva Pharmaceutical Industries Ltd.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Hikma Pharmaceuticals PLC
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dr. Reddy's Laboratories Ltd
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novartis AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Eli Lilly and Company
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Headache Disorders Market

29. Headache Disorders Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!